American Cancer Society’s VC arm partners with Third Rock on oncology companies

Cancer startups aren’t exactly underfunded — as a disease area, oncology has commanded investors’ attention for the last decade.

But the American Cancer Society sees gaps.

“Oncology actually is very well-resourced and invested in. The challenge is, is the money going to the areas where there’s the greatest impact?” said Alice Pomponio, the managing director of the society’s venture capital arm, BrightEdge.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In